Vicki Shanker
Overview
Explore the profile of Vicki Shanker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lemus H, Gutierrez C, Fields M, Ziemba K, Landazuri P, Shanker V, et al.
J Clin Neurophysiol
. 2024 Dec;
PMID: 39668416
Purpose: To investigate the utility of a 15-minute online module to improve the self-confidence and knowledge of neurology trainees when screening an EEG. Methods: We developed a fast, convenient, and...
2.
Miltenberger-Miltenyi G, Ortega R, Domingo A, Yadav R, Nishiyama A, Raymond D, et al.
NPJ Parkinsons Dis
. 2023 Dec;
9(1):160.
PMID: 38062033
There is a paucity of genetic characterization in people with Parkinson's disease (PD) of Latino and Afro-Caribbean descent. Screening LRRK2 and GBA variants in 32 New Yorkers of Puerto Rican...
3.
Ortega R, Bressman S, Raymond D, Ozelius L, Katsnelson V, Leaver K, et al.
Mov Disord
. 2022 Sep;
37(11):2217-2225.
PMID: 36054306
Background: Although men and women with the LRRK2 G2019S variant appear to be equally likely to have Parkinson's disease (PD), the sex-distribution among glucocerebrosidase (GBA) variant carriers with PD, including...
4.
Saunders-Pullman R, Ortega R, Wang C, Raymond D, Elango S, Leaver K, et al.
Neurology
. 2022 Aug;
99(8):e814-e823.
PMID: 35995594
Background And Objectives: There is clinical and phenotypic heterogeneity in G2019S Parkinson disease (PD), including loss of smell. Olfactory scores have defined subgroups of PD at baseline. We now extend...
5.
Navarro E, Udine E, de Paiva Lopes K, Parks M, Riboldi G, Schilder B, et al.
Nat Aging
. 2022 Jan;
1(9):850-863.
PMID: 35005630
An increasing number of identified Parkinson's disease (PD) risk loci contain genes highly expressed in innate immune cells, yet their role in pathology is not understood. We hypothesize that PD...
6.
Pal G, Mangone G, Hill E, Ouyang B, Liu Y, Lythe V, et al.
Ann Neurol
. 2022 Jan;
91(3):424-435.
PMID: 34984729
Objective: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in...
7.
Moran E, Bressman S, Ortega R, Raymond D, Nichols W, Palmese C, et al.
Front Neurol
. 2021 Mar;
12:635958.
PMID: 33716938
Mutations and variants in the glucocerebrosidase () gene are among the most common genetic risk factors for the development of Parkinson's disease (PD). Yet, penetrance is markedly reduced, and less...
8.
Shanker V
BMJ
. 2019 Aug;
366:l4485.
PMID: 31383632
Essential tremor is one of the most common movement disorders in adults and can affect both children and adults. An updated consensus statement in 2018 redefined essential tremor as an...
9.
Swan M, Doan N, Ortega R, Barrett M, Nichols W, Ozelius L, et al.
J Neurol Sci
. 2016 Oct;
370:63-69.
PMID: 27772789
Mutations in GBA1 are a well-established risk factor for Parkinson disease (PD). GBA-associated PD (GBA-PD) may have a higher burden of nonmotor symptoms than idiopathic PD (IPD). We sought to...
10.
Shanker V, Bressman S
Continuum (Minneap Minn)
. 2016 Aug;
22(4 Movement Disorders):1227-45.
PMID: 27495206
Purpose Of Review: This article highlights the clinical and diagnostic tools used to assess and classify dystonia and provides an overview of the treatment approach. Recent Findings: In the past...